29
Oversold
Moving averages
SMA 200$2.45-40.00%
Company profile
NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. The company is headquartered in Edinburgh, the United Kingdom.
SectorHealthcare
IndustryBiotechnology
Market cap$5.99M
P/E ratio0.0107
EPS$134.90
Beta2.218
Dividend yield0.00%
52-week high$7.22
52-week low$1.21
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 52
VRTX
Vertex Pharmaceuticals Inc
RSI 64
CRSP
CRISPR Therapeutics AG
RSI 54
IOVA
Iovance Biotherapeutics Inc
RSI 66
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 51
MRNA
Moderna Inc
RSI 67
VKTX
Viking Therapeutics Inc
RSI 49
SRPT
Sarepta Therapeutics Inc
RSI 67
EDIT
Editas Medicine Inc
RSI 52
NVAX
Novavax Inc
RSI 72
RSI alerts for NCNA
Get an email the moment NuCana PLC crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 11:23 PM EDT